Total Debt
$3.38B
Net Debt
$2.44B
BridgeBio Pharma, Inc. currently has $3.38B in total debt. Net debt is $2.44B after cash offsets.
Financial Fundamentals
BBIO • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 3.38 | 0.94 | 2.44 | 1.37 | 246.9% |
| 2025-12-31 | 2.73 | 0.59 | 2.14 | 0.94 | 291.5% |
| 2025-09-30 | 1.86 | 0.65 | 1.21 | 1.00 | 186.3% |
| 2025-06-30 | 2.68 | 0.76 | 1.92 | 1.08 | 247.8% |
| 2025-03-31 | 1.86 | 0.54 | 1.32 | 0.88 | 210.8% |
| 2024-12-31 | 1.73 | 0.68 | 1.05 | 0.92 | 188.2% |
| 2024-09-30 | 1.73 | 0.27 | 1.46 | 0.66 | 260.1% |
| 2024-06-30 | 1.73 | 0.59 | 1.14 | 0.79 | 217.7% |
| 2024-03-31 | 1.73 | 0.52 | 1.21 | 0.85 | 203.5% |
| 2023-12-31 | 1.74 | 0.43 | 1.30 | 0.55 | 318.4% |
| 2023-09-30 | 1.74 | 0.54 | 1.19 | 0.66 | 264.9% |
| 2023-06-30 | 1.73 | 0.38 | 1.35 | 0.50 | 344.2% |
| 2023-03-31 | 1.73 | 0.52 | 1.21 | 0.63 | 276.3% |
| 2022-12-31 | 1.72 | 0.47 | 1.25 | 0.62 | 276.6% |
| 2022-09-30 | 1.72 | 0.59 | 1.12 | 0.73 | 235.4% |
| 2022-06-30 | 1.71 | 0.72 | 1.00 | 0.86 | 198.5% |
| 2022-03-31 | 1.73 | 0.67 | 1.06 | 0.81 | 212.5% |
| 2021-12-31 | 1.73 | 0.84 | 0.89 | 1.01 | 170.4% |
| 2021-09-30 | 1.40 | 0.60 | 0.80 | 0.78 | 179.0% |
| 2021-06-30 | 1.40 | 0.84 | 0.56 | 1.08 | 129.3% |
| 2021-03-31 | 1.38 | 0.92 | 0.46 | 1.09 | 126.5% |
| 2020-12-31 | 0.50 | 0.61 | -0.11Net Cash | 0.70 | 70.5% |
| 2020-09-30 | 0.48 | 0.71 | -0.23Net Cash | 0.79 | 61.4% |
| 2020-06-30 | 0.48 | 0.84 | -0.36Net Cash | 0.91 | 52.9% |
| 2020-03-31 | 0.47 | 0.91 | -0.43Net Cash | 0.99 | 47.7% |
| 2019-12-31 | 0.09 | 0.55 | -0.45Net Cash | 0.63 | 14.5% |
| 2019-09-30 | 0.08 | 0.54 | -0.46Net Cash | 0.64 | 11.7% |
| 2019-06-30 | 0.07 | 0.29 | -0.22Net Cash | 0.33 | 23.0% |
| 2019-03-31 | 0.05 | 0.37 | -0.32Net Cash | 0.40 | 13.7% |
| 2018-12-31 | 0.05 | 0.44 | -0.38Net Cash | 0.46 | 11.7% |
| 2018-03-31 | 0.00 | 0.09 | -0.09Net Cash | 0.00 | — |